News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlaxoSmithKline (GSK) CEO Has Bigger Problem Than China As Sales Drop



7/24/2014 6:45:35 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Andrew Witty, chief executive officer of GlaxoSmithKline Plc (GSK), has a challenge overseas. It’s just not the one that’s been making headlines.

While the media has been obsessed with the corruption investigation that has enveloped Glaxo in China, investors are more worried about the U.K. drugmaker’s disappointing performance, and particularly sales of its hallmark respiratory medicines in the U.S.

Help employers find you! Check out all the jobs and post your resume.

Read at Bloomberg
Read at New York Times
Read at Philadelphia Inquirer
Read at Forbes
Read at Wall Street Journal


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES